Reintroduced Humane Cosmetics Act Mum On FDA’s Role

While the previous session’s iteration of the Humane Cosmetics Act attracted support from nearly 40% of the House, it did not advance – a fate sponsors hope to avoid with broad bipartisan support and assurances that the bill would not hurt businesses.

The reintroduced Humane Cosmetics Act may again face an uphill battle, despite support from both sides of the aisle, given competing administration priorities and continuing uncertainties on substantiating product safety without FDA’s acceptance of certain alternative tests.

The bill will likely not be a priority following President Trump’s vow to cut regulations, though industry is hoping the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legislation

More from Policy & Regulation